Caplin Point surges after strong Q2 results

Caplin Point Laboratories was up 2.97% to Rs 377.95 at 14:50 IST on BSE after consolidated net profit surged 60.22% to Rs 22.56 crore on 23.44% growth in income from operations to Rs 95.72 crore in Q2 September 2016 over Q2 September 2015.

The result was announced after market hours yesterday, 9 November 2016.

Meanwhile, the S&P BSE Sensex was up 328.18 points or 1.2% at 27,580.71.

On BSE, so far 29,000 shares were traded in the counter as against average daily volume of 49,000 shares in the past two weeks. The stock hit a high of Rs 399 and a low of Rs 376.10 so far during the day.

 

Caplin Point Laboratories is a pharmaceutical company, catering predominantly to emerging markets of Latin America and Africa.

Powered by Capital Market - Live News